MIT researchers have found that reduced plasticity in the brains of people with dyslexia may explain why they experience difficulties with reading and with processing spoken speech, writes Kevin Murnane of Forbes. Murnane explains that the findings “indicate that dyslexia is not just about reading. It involves a reduction in neural adaptation to a variety of perceptual stimuli.”
In this piece for The New Yorker, Michael Specter writes about Prof. Kevin Esvelt’s idea to use gene-editing technology to eradicate Lyme disease. “This is an ecological problem,” Esvelt explains. “And we want to enact an ecological solution so that we break the transmission cycle that keeps ticks in the environment infected with these pathogens.”
TIME reporter Alice Park writes about a study by Prof. John Gabrieli that shows that the difficulty people with dyslexia experience when reading could be caused by reduced plasticity in the brain. “We need to figure out a curriculum or approach that matches the differences they have,” explains Gabrieli.
A new study co-authored by Prof. John Gabrieli shows that the brains of people with dyslexia respond differently not only to words, but also objects and faces, reports Felice Freyer for The Boston Globe. The findings point to “the core biological difference in the brains of people with dyslexia,” explains Prof. John Gabrieli.
Prof. James Collins has been named one of The Boston Globe’s “2016 Bostonians of the Year” for his work developing a paper-based test that can detect the Zika virus in just a few hours. Neil Swidey notes that Collins also developed a “workflow for how this new platform could be adapted to meet future crises.”
A paper-based test that can detect the Zika virus, developed by Prof. James Collins and his research team, is featured in a list of the year’s most important health innovations compiled Alyssa Favreau and Claire Maldarelli for Popular Science. Unlike conventional lab tests, the paper-based test can provide results within three hours.
MIT researchers have developed a stretchy, biocompatible material that could be implanted in a patient’s body and used to stimulate cells or detect disease, according to FOX News. The hydrogel “could bend and twist in a patient’s body without breaking down.”
Guardian reporter Amy Fleming spotlights Prof. Robert Langer’s work revolutionizing medicine. Fleming notes that “Langer’s trailblazing research in nanotechnology, which ranges from haircare to cancer treatments, has already improved the lives of at least 2 billion people.”
MIT researchers have developed a new technique to stop the spread of cancer cells through the body by delivering microRNAs to the site of the primary tumor, reports Hallie Smith for Boston Magazine. The technique “may correct gene disruptions that put a patient at risk of metastatic cancer,” Smith explains.
STAT reporter Sharon Begley writes that MIT will share the One Brave Idea research award, which is focused on supporting research aimed at fighting heart disease. The award recipients plan “to hunt down so-far unrecognized signals marking the transition from a healthy heart to one on the road to disease.”
Popular Science reporter Sarah Chodosh writes that MIT researchers have developed a strategy to deliver beneficial bacteria to the GI tract. The researchers used layers of different sugars "to coat individual cells of Bacillus coagulans, which is used to treat irritable bowel syndrome."
In an article for U.S. News & World Report, Robert Preidt writes that researchers from MIT and the University of Oxford have found that atrial fibrillation is tied to a wider range of conditions than initially thought. The researchers found that the disorder was associated with “heart disease, heart failure, kidney disease, sudden cardiac death and death from all causes.”
Natasha Hinde writes for The Huffington Post about a new study co-authored by MIT examining people with irregular heartbeats. The researchers found that “atrial fibrillation was associated with an increased risk of ischaemic heart disease (coronary artery disease), chronic kidney disease, heart failure and sudden cardiac death.”
MIT researchers have developed a new way to record the activities of human cells, reports Kevin Hartnett for The Boston Globe. “Most of the studies we do to understand diseases like cancer and Alzheimer’s involve studying cells in a dish. We’re interested in understanding how cells function in their natural environments,” explains Prof. Timothy Lu.
Boston Magazine reporter Dana Guth writes that MIT researchers are programming harmless strains of E. coli bacteria to destroy tumor cells. Guth explains that the programmed bacteria could be ingested or injected and “could offer a new way to stave off liver cancer.”